2022-05-11 16:19:34 MYO Myomo
05/11/22 05/1116:19 05/11/2216:19 | Myomo reports Q1 EPS (41c), consensus (53c)Reports Q1 revenue $3.9M, consensus $2.9M. CEO Paul Gudonis says: "First quarter product revenue was in line with our expectations, with growth reflecting a higher number of MyoPro units sold, strong results in international markets and a leveling off in ASP-related growth as the percentage of product revenue from the direct-billing channel matures. Pipeline additions grew during the quarter due to a combination of new leads from our marketing efforts and from previously interested patients who are now moving ahead to obtain a MyoPro. We continue to adapt and expand the breadth of our marketing and patient education strategies in the dynamic online environment to cost-effectively introduce the MyoPro to more candidates. Our joint venture in China is nearing the start-up of operations, with receipt of the initial $1.0 million license payment during the first quarter. We expect operations to launch in the second half of this year after payment of the remainder of the license fee, which is expected before the end of the second quarter. In Europe, our sales organization has been very effective in raising awareness of the MyoPro, particularly in Germany where we have been reimbursed by statutory health insurance plans that cover 52% of the population. In support of our goal to better control our supply chain, in-house manufacturing of the MyoPro2+ began during the quarter and is proceeding well. In addition, there have been no major changes with respect to reimbursement from our largest payer, where we continue to receive new authorizations and payment after filing post-delivery appeals. We further diversified our payer base with first-time authorizations during the quarter from several Medicare Advantage programs and state Blue Cross Blue Shield plans." |
|
---|
General news
| Market Update: Asian… Story temporarily locked. ShowHide Related Items >><<
|
General news
|
China economy bounces back thanks to services. »
02:25 02/03/23 02/0302:25 02/03/2302:25
$ECON
Economic Data
China economy bounces… Story temporarily locked. ShowHide Related Items >><<
|
Conference/Events
|
Piper Sandler economist to hold an analyst/industry conference call »
22:33 02/02/23 02/0222:33 02/02/2322:33
Chief Economist Lazar and… Chief Economist Lazar and Head of Global Policy Perli discuss payrolls and their implications on an Analyst/Industry conference call to be held on February 3 at 8:45 am. Webcast Link |
Conference/Events
|
Cowen medical devices analyst to hold analyst/industry conference call »
22:24 02/02/23 02/0222:24 02/02/2322:24
Medical Devices Analyst… Medical Devices Analyst Jennings, along with Dr. Shephal Doshi, Director of Cardiac Electrophysiology at Pacific Heart Institute, discuss the market dynamics of the U.S. Left Atrial Appendage Closure (LAAC) Duopoly on an Analyst/Industry conference call to be held on February 7 at 12:30 pm. Webcast Link |
Syndicate
|
Avalo Therapeutics 3.77M share Spot Secondary priced at $3.98 »
21:56 02/02/23 02/0221:56 02/02/2321:56
AVTX
Avalo Therapeutics
SVB Securities and RBC… SVB Securities and RBC Capital are acting as joint book running managers for the offering. ShowHide Related Items >><<
|
Recommendations
|
Conmed price target raised to $118 from $108 at Piper Sandler »
21:55 02/02/23 02/0221:55 02/02/2321:55
CNMD
Conmed
Piper Sandler analyst… Piper Sandler analyst Matt O'Brien raised the firm's price target on Conmed to $118 from $108 and keeps an Overweight rating on the shares. The company unsurprisingly missed on Q4 earnings and revenue due to a previously disclosed Software Implementation issue, but this should be a transitory factor, the analyst tells investors in a research note. Conmed's key growth drivers - the Smoke business, In2Bones and Biorez - remain strong and should stay that way through 2023 and beyond, the firm adds. ShowHide Related Items >><<
|
Syndicate
|
Roivant Sciences 26.67M share Secondary priced at $7.50 »
21:17 02/02/23 02/0221:17 02/02/2321:17
ROIV
Roivant Sciences
The deal size was… The deal size was increased to $200M from $150M and priced below last closing price of $7.59. Goldman Sachs, SVB Securities, Cowen and Cantor Fitzgerald are acting as joint book running managers for the offering. ShowHide Related Items >><<
|
Syndicate
|
Edible Garden 1.62M share Spot Secondary priced at $6.30 »
20:43 02/02/23 02/0220:43 02/02/2320:43
EDBL
Edible Garden
The deal priced below… The deal priced below last closing price of $8.35. Maxim and Joseph Gunnar are acting as joint book running managers for the offering. ShowHide Related Items >><<
|
Hot Stocks
|
Dutch Bros CEO sells $6.0M in common stock »
20:39 02/02/23 02/0220:39 02/02/2320:39
BROS
Dutch Bros
In a regulatory filing,… In a regulatory filing, Dutch Bros disclosed that its CEO Jonathan Ricci sold 160K shares of common stock on February 1 in a total transaction size of $6.0M. ShowHide Related Items >><<
|
Earnings
|
Notable companies reporting before tomorrow's open »
20:25 02/02/23 02/0220:25 02/02/2320:25
CI
Cigna
Regeneron
Zimmer Biomet
Church & Dwight
Saia
Notable companies… Notable companies reporting before tomorrow's open, with earnings consensus, include Cigna (CI), consensus $4.86... Regneron (REGN), consensus $10.03... Zimmer Biomet (ZBH), consensus $1.83... Church & Dwight (CHD), consensus 60c... Saia (SAIA), consensus $2.83. ShowHide Related Items >><<
|
Hot Stocks
|
Nordstrom ends afterhours session up 31% after WSJ report on Ryan Cohen stake
20:16 02/02/23 02/0220:16 02/02/2320:16
JWN
Nordstrom
ShowHide Related Items >><<
|
Hot Stocks
|
Cathie Wood's ARK Investment bought 56.1K shares of Velo3D today
20:09 02/02/23 02/0220:09 02/02/2320:09
VLD
Velo3D
ShowHide Related Items >><<
|
Syndicate
|
Structure Therapeutics 10.74M share IPO priced at $15.00 »
19:49 02/02/23 02/0219:49 02/02/2319:49
GPCR
Structure Therapeutics
The deal priced at high… The deal priced at high end of $13.00-$15.00 range. Jefferies, SVB Securities, Guggenheim and BMO Capital are acting as joint book running managers for the offering. ShowHide Related Items >><< |
Downgrade
|
Focus Financial downgraded to Market Perform from Outperform at BMO Capital »
19:38 02/02/23 02/0219:38 02/02/2319:38
FOCS
Focus Financial
BMO Capital analyst James… BMO Capital analyst James Fotheringham downgraded Focus Financial to Market Perform from Outperform with a price target of $53, down from $55. The analyst cites the company's announced acquisition proposal from Clayton, Dubilier & Rice at $53 per share, also stating that since this is an exclusivity agreement, a competing bid is not expected. ShowHide Related Items >><<
|
Hot Stocks
|
Avista raises quarterly dividend 4.5% to 46c per share »
19:08 02/02/23 02/0219:08 02/02/2319:08
AVA
Avista
Avista Corp.'s board… Avista Corp.'s board of directors has declared a quarterly dividend of 46c per share on the company's common stock, an increase of 2c per share or 4.5%, yielding an annualized dividend of $1.84. The common stock dividend is payable March 15, 2023, to shareholders of record at the close of business on Feb. 17, 2023. "The dividend increase approved by the board of directors marks the twenty-first consecutive year the board has raised the dividend for our shareholders. I believe it demonstrates the board's commitment to maximizing shareholder value," said Avista President and Chief Executive Officer Dennis Vermillion. ShowHide Related Items >><<
|
Periodicals
|
Ryan Cohen amasses sizable stake in Nordstrom, WSJ reports »
19:05 02/02/23 02/0219:05 02/02/2319:05
JWN
Nordstrom
GameStop
Chewy
Activist investor Ryan… Activist investor Ryan Cohen has taken a sizable stake in Nordstrom (JWN) and plans to urge the company to make changes to its board following a major stock dip, the Wall Street Journal's Lauren Thomas reports, citing people familiar with the matter. Cohen, known for helping ignite large rallies in stocks like GameStop (GME) and for co-founding Chewy (CHWY), is one of the top-five nonfamily investors in Nordstrom, Thomas notes. Reference Link ShowHide Related Items >><<
|
On The Fly
|
Fly Intel: After-Hours Movers »
18:53 02/02/23 02/0218:53 02/02/2318:53
MWA
Mueller Water
Boyd Gaming
Paylocity
Clorox
Gilead
OpenText
Bill.com
Atlassian
Ford
Conmed
Leslie's
SkyWest
Amazon.com
2U
MicroStrategy
Alphabet
Qualcomm
Microchip
Cirrus Logic
Skechers
Apple
Exponent
Starbucks
Cognizant
Silvergate Capital
Check out this evening's… ShowHide Related Items >><<
|
Upgrade
|
Wereldhave upgraded to Outperform from Neutral at Oddo BHF »
18:38 02/02/23 02/0218:38 02/02/2318:38
WRDEF
Wereldhave
Oddo BHF analyst Steven… Oddo BHF analyst Steven Boumans upgraded Wereldhave to Outperform from Neutral with a EUR 17 price target. ShowHide Related Items >><<
|
Downgrade
|
VGP NV downgraded to Underperform from Neutral at Oddo BHF »
18:38 02/02/23 02/0218:38 02/02/2318:38
VGPBF
VGP NV
Oddo BHF analyst Gerardo… Oddo BHF analyst Gerardo Ibanez downgraded VGP NV to Underperform from Neutral with a EUR 74 price target. ShowHide Related Items >><<
|
Hot Stocks
|
Marathon Digital reports 687 BTC produced in January »
18:34 02/02/23 02/0218:34 02/02/2318:34
MARA
Marathon Digital
Bitcoin
Bitcoin
Reports January installed… Reports January installed Hash Rate 11.0, 206% increase from last year. Marathon Digital Holdings published unaudited bitcoin production and miner installation updates for January 2023. "We started the year by producing a record 687 bitcoin in January 2023, which is a 45% increase from the 475 bitcoin we produced in December 2022," said Fred Thiel, Marathon's chairman and CEO. "The improvement in our bitcoin production was primarily a result of our team's ability to work in tandem with the new hosting provider in McCamey, Texas, to address the maintenance and technical issues at the King Mountain data center that had suppressed our bitcoin production in the fourth quarter of 2022. We believe the improvements in our operational efficiency, along with the proactive measures we have taken to strengthen our balance sheet, have placed Marathon in a strong position to achieve our growth and operational targets in 2023. With bitcoin production increasing and becoming more consistent, we made the strategic decision to sell some of our bitcoin, as previously planned, to cover some of our operating expenses and for general corporate purposes. We intend to continue to sell a portion of our bitcoin holdings in 2023 to fund monthly operating costs. Even with these sales, our unrestricted bitcoin holdings increased from 7,815 bitcoin as of December 31, 2022, to 8,090 bitcoin as of January 31, 2023, as our production improved and the appreciation in bitcoin's price in January reduced the amount of bitcoin we had posted as collateral. Additionally, we ended the month with $133.8M in unrestricted cash on hand. As we look ahead, our focus for the year is to energize more miners and to optimize their performance. We remain confident in our ability to scale Marathon into one of the largest and most energy efficient Bitcoin mining operations globally by installing approximately 23 exahashes of computing power near the middle of 2023." ShowHide Related Items >><<
|
Recommendations
|
Parker-Hannifin price target raised to $403 from $385 at Baird »
18:26 02/02/23 02/0218:26 02/02/2318:26
PH
Parker-Hannifin
Baird analyst Mircea… Baird analyst Mircea Dobre raised the firm's price target on Parker-Hannifin to $403 from $385 and keeps an Outperform rating on the shares. The analyst cites the company's strong quarter driving another full year guidance raise, with orders reported much better than anticipated thanks to solid OEM customer backlogs. The firm adds that Parker-Hannifin shares remain attractively valued relative to peers. ShowHide Related Items >><<
|
Hot Stocks
|
Netflix, GM partner to increase EV presence in Netflix-produced shows, films »
18:25 02/02/23 02/0218:25 02/02/2318:25
NFLX
Netflix
General Motors
General Motors (GM) and… General Motors (GM) and Netflix (NFLX) are partnering to increase the presence of electric vehicles in Netflix-produced shows and films, where relevant, while also taking steps to enable more sustainable productions. "Entertainment has a huge impact on culture. We want to make EVs famous on streaming, small and silver screens to build an EV culture through storytelling that incorporates the experiences of driving and owning an EV," said GM Global Chief Marketing Officer Deborah Wahl. "Netflix is a great partner because of the company's compelling storytelling, commitment to sustainability and track record of sparking conversations that shape cultural trends. We are united in creating a better, more sustainable future for our world as we bring everybody in on EVs." As a result of the partnership, Netflix is supporting and educating creators, helping them to better understand how EVs can complement and enhance their stories. Over the course of the next year, inspired by this partnership, GM EVs will be seen in select Netflix shows and films, including Love is Blind, Queer Eye and Unstable, which will feature the Chevrolet Bolt EUV, GMC HUMMER EV Pickup and Cadillac LYRIQ respectively. Reference Link ShowHide Related Items >><<
|
Hot Stocks
|
Cadence Design Chairman sells $5.47M in common stock »
18:23 02/02/23 02/0218:23 02/02/2318:23
CDNS
Cadence Design
In a regulatory filing,… In a regulatory filing, Cadence Design disclosed that its Executive Chair Lip-Bu Tan sold 30K shares of common stock on January 31st in a total transaction size of $5.47M. ShowHide Related Items >><<
|
Recommendations
|
CNH Industrial price target raised to $21 from $17 at Baird »
18:21 02/02/23 02/0218:21 02/02/2318:21
CNHI
CNH Industrial
Baird analyst Mircea… Baird analyst Mircea Dobre raised the firm's price target on CNH Industrial to $21 from $17 and keeps an Outperform rating on the shares. The analyst said that, following CNH's Q4 report, the company's 2023 is set for solid growth, adding that the firm is monitoring order progression into 2024. Baird added that it sees sufficient catalysts in 2023 given solid earnings momentum. ShowHide Related Items >><<
|
Recommendations
|
Illinois Tool Works price target raised to $255 from $222 at Baird »
18:20 02/02/23 02/0218:20 02/02/2318:20
ITW
Illinois Tool Works
Baird analyst Mircea… Baird analyst Mircea Dobre raised the firm's price target on Illinois Tool Works to $255 from $222 but keeps a Neutral rating on the shares. The company's Q4 results were "solid" with 12% organic sales growth and operating margin expansion of 210bps y/y, the analyst tells investors in a research note. The firm notes however that at 28-times expected 2023 earnings, the stock's valuation at its implied price target is at a "premium" relative to its peers. ShowHide Related Items >><<
|